PLoS ONE (Jan 2016)

The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice.

  • Hideyuki Ogiso,
  • Hiroyasu Ito,
  • Tatsuya Ando,
  • Yuko Arioka,
  • Ayumu Kanbe,
  • Kazuki Ando,
  • Tetsuya Ishikawa,
  • Kuniaki Saito,
  • Akira Hara,
  • Hisataka Moriwaki,
  • Masahito Shimizu,
  • Mitsuru Seishima

DOI
https://doi.org/10.1371/journal.pone.0162183
Journal volume & issue
Vol. 11, no. 9
p. e0162183

Abstract

Read online

In the present study, we examined the role of indoleamine 2,3-dioxygenase (IDO) in the development of CCl4-induced hepatic fibrosis. The liver fibrosis induced by repetitive administration with CCl4 was aggravated in IDO-KO mice compared to WT mice. In IDO-KO mice treated with CCl4, the number of several inflammatory cells and the expression of pro-inflammatory cytokines increased in the liver. In the results, activated hepatic stellate cells (HSCs) and fibrogenic factors on HSCs increased after repetitive CCl4 administration in IDO-KO mice compared to WT mice. Moreover, the treatment with l-tryptophan aggravated the CCl4-induced hepatic fibrosis in WT mice. Our findings demonstrated that the IDO deficiency enhanced the inflammation in the liver and aggravated liver fibrosis in repetitive CCl4-treated mice.